PayPay Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93K Hold
5
0.05% 171
2026
Q1
$1.58K Sell
5
-1
-17% -$329 0.05% 196
2025
Q4
$2.1K Buy
6
+1
+20% +$338 0.06% 180
2025
Q3
$1.65K Buy
5
+1
+25% +$311 0.06% 184
2025
Q2
$1.56K Buy
4
+1
+33% +$402 0.08% 174
2025
Q1
$1.34K Sell
3
-4
-57% -$1.61K 0.08% 202
2024
Q4
$2.58K Buy
+7
New +$2.93K 0.11% 152

Other funds holding ELV

PayPay Securities's ELV Position: Q2 2026 in Review

PayPay Securities held its Elevance Health (ELV) position steady in Q2 2026 at 5 shares worth $1.93K. The position accounts for 0.05% of the portfolio, ranked #171.

PayPay Securities first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.58K in Q4 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • PayPay Securities held 5 shares of Elevance Health worth $1.93K as of Q2 2026.
  • PayPay Securities left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.05% of PayPay Securities's portfolio in Q2 2026, its #171 holding.
  • PayPay Securities first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • PayPay Securities's Elevance Health position peaked at $2.58K in Q4 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.